Last edition
News about "VAV Life Sciences Covid-19 vaccines"
VAV Life Sciences invests Rs.15 crore to expand capacity for lipids used in Covid-19 vaccines
Mumbai-based VAV Life Sciences, through its subsidiary VAV Lipids, has announced it has invested Rs.15 crore (US$ 2 million) to boost production capacity to meet the unprecedented overseas demand for lipidic ingredients
VAV Life Sciences Covid-19 Vaccines | 24/11/2021 | By Darshana | 716
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members